![]() |
Doug Macron is the editor of GenomeWeb's Gene Silencing News. He covers research and therapeutic applications of RNAi, miRNA, and other gene-silencing technologies. E-mail Doug Macron or follow his GenomeWeb Twitter account at @Genesilencing. |
Galena Settles Investor Lawsuits Following Successful RXi Spinout
New to GenomeWeb? Register here quickly.
